A carregar...
TMOD-30. TARGETING AN OLIG2-DEPENDENT PATHWAY TO INHIBIT TUMOR GROWTH IN PRIMARY AND RECURRENT MEDULLOBLASTOMA
Medulloblastoma represents the most common childhood malignant brain tumor. Despite aggressive multimodal therapy, a significant proportion of surviving patients suffer from severe treatment-related side effects, including tumor relapse. Thus, there is an urgent need for novel therapeutic modalities...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692633/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.1067 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|